ID27214A - Triazolopiridina untuk pengobatan gangguan trombosis - Google Patents

Triazolopiridina untuk pengobatan gangguan trombosis

Info

Publication number
ID27214A
ID27214A IDW20010365A ID20010365A ID27214A ID 27214 A ID27214 A ID 27214A ID W20010365 A IDW20010365 A ID W20010365A ID 20010365 A ID20010365 A ID 20010365A ID 27214 A ID27214 A ID 27214A
Authority
ID
Indonesia
Prior art keywords
triazolopiridina
trombosis
disorders
treatment
trombosis disorders
Prior art date
Application number
IDW20010365A
Other languages
English (en)
Indonesian (id)
Inventor
William J Hoekstra
Edward C Lawson
Bruce E Maryanoff
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Publication of ID27214A publication Critical patent/ID27214A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
IDW20010365A 1998-07-27 1999-07-21 Triazolopiridina untuk pengobatan gangguan trombosis ID27214A (id)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9423198P 1998-07-27 1998-07-27
US09/354,032 US6303625B1 (en) 1998-07-27 1999-07-15 Triazolopyridines for the treatment of thrombosis disorders

Publications (1)

Publication Number Publication Date
ID27214A true ID27214A (id) 2001-03-08

Family

ID=22243910

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW20010365A ID27214A (id) 1998-07-27 1999-07-21 Triazolopiridina untuk pengobatan gangguan trombosis

Country Status (21)

Country Link
US (1) US6303625B1 (pt)
EP (1) EP1102766B1 (pt)
JP (1) JP2003527306A (pt)
KR (1) KR20010079576A (pt)
CN (1) CN1320125A (pt)
AR (1) AR019477A1 (pt)
AT (1) ATE263169T1 (pt)
AU (1) AU757512B2 (pt)
BR (1) BR9912556A (pt)
CA (1) CA2338654A1 (pt)
CZ (1) CZ2001347A3 (pt)
DE (1) DE69916073T2 (pt)
ES (1) ES2219042T3 (pt)
HU (1) HUP0103832A3 (pt)
ID (1) ID27214A (pt)
MX (1) MXPA01001099A (pt)
NO (1) NO20010456L (pt)
PL (1) PL345769A1 (pt)
SK (1) SK1342001A3 (pt)
WO (1) WO2000006570A1 (pt)
ZA (1) ZA200100783B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306909B1 (en) 1997-03-12 2001-10-23 Queen's University At Kingston Anti-epileptogenic agents
CZ2002518A3 (cs) * 1999-08-13 2002-05-15 Biogen, Inc. Inhibitory buněčné adheze a farmaceutické prostředky, které je obsahují
TWI290136B (en) * 2000-04-05 2007-11-21 Daiichi Seiyaku Co Ethylenediamine derivatives
JP2004536071A (ja) * 2001-05-25 2004-12-02 クイーンズ ユニバーシティ アット キングストン 複素環ベータアミノ酸およびそれらの抗癲癇誘発剤としての使用
WO2003000657A1 (fr) 2001-06-20 2003-01-03 Daiichi Pharmaceutical Co., Ltd. Derives de diamine
WO2006018727A2 (en) * 2004-08-18 2006-02-23 Pharmacia & Upjohn Company Llc Triazolopyridine compounds useful for the treatment of inflammation
US7618983B2 (en) * 2004-11-10 2009-11-17 Janssen Pharmaceutica, N.V. Bicyclic triazole α4 integrin inhibitors
HUE029336T2 (en) * 2005-09-16 2017-02-28 Daiichi Sankyo Co Ltd For the preparation of an optically active diamine derivative and process
WO2008045393A2 (en) * 2006-10-11 2008-04-17 Amgen Inc. Imidazo- and triazolo-pyridine compounds and methods of use therof
EP2417135A1 (en) * 2009-04-07 2012-02-15 Schering Corporation Substituted triazolopyridines and analogs thereof
US8871760B2 (en) * 2009-09-21 2014-10-28 Roche Palo Alto Llc [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
MX339302B (es) 2011-09-15 2016-05-19 Novartis Ag 3-(quinolin-6-il-tio)-[1,2,4]-triazolo-[4,3-a]-piridinas 6-sustituidas como cinasas de tirosina.
EP3004095A1 (de) * 2013-06-03 2016-04-13 Bayer Pharma Aktiengesellschaft Triazolopyridine als thrombininhibitoren zur behandlung von thromboembolischen erkrankungen
GB201511382D0 (en) 2015-06-29 2015-08-12 Imp Innovations Ltd Novel compounds and their use in therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3050525A (en) 1960-12-14 1962-08-21 John B Bicking Certain derivatives of s-triazolo [4, 3-a]-pyridine
NZ262664A (en) 1993-02-22 1997-04-24 Merck & Co Inc Heterocyclic substituted derivatives, and medicaments thereof
DE4326758A1 (de) * 1993-08-10 1995-02-16 Basf Ag [1,3,4]Triazolo[1,5-a]pyridine
CA2134192A1 (en) 1993-11-12 1995-05-13 Michael L. Denney 5, 6-bicyclic glycoprotein iib/iiia antagonists

Also Published As

Publication number Publication date
JP2003527306A (ja) 2003-09-16
EP1102766A1 (en) 2001-05-30
WO2000006570A1 (en) 2000-02-10
ES2219042T3 (es) 2004-11-16
AU5221899A (en) 2000-02-21
PL345769A1 (en) 2002-01-02
HUP0103832A3 (en) 2002-12-28
CZ2001347A3 (cs) 2001-12-12
HUP0103832A2 (hu) 2002-04-29
US6303625B1 (en) 2001-10-16
ZA200100783B (en) 2002-01-28
NO20010456D0 (no) 2001-01-26
SK1342001A3 (en) 2002-04-04
DE69916073D1 (de) 2004-05-06
NO20010456L (no) 2001-03-26
CN1320125A (zh) 2001-10-31
DE69916073T2 (de) 2004-12-30
CA2338654A1 (en) 2000-02-10
AR019477A1 (es) 2002-02-20
AU757512B2 (en) 2003-02-20
ATE263169T1 (de) 2004-04-15
MXPA01001099A (es) 2002-04-24
EP1102766B1 (en) 2004-03-31
KR20010079576A (ko) 2001-08-22
BR9912556A (pt) 2002-01-15

Similar Documents

Publication Publication Date Title
NO993051D0 (no) Intranasale formuleringer for behandling av seksuelle forstyrrelser
DE69936335D1 (de) Verwendung von morpholinol zur behandlung von sexuellen funktionsstörungen
NO20004688L (no) Terapi ved østrogenassosierte lidelser
ID30276A (id) Metode untuk mengobati gangguan-gangguan seksual
PT1077940E (pt) 4-fenilpiperidinas novas para o tratamento de dermatoses pruriginosas
NO20001870L (no) Ny fremgangsmÕte for behandling
NO20005884L (no) Kombinasjonsterapi for behandling av bipolare forstyrrelser
ID27191A (id) Metode untuk pengobatan insomnia
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
IS5951A (is) 5HT1 mótlyf fyrir meðferð gegn þunglyndi
NO20012106L (no) Middel for behandling av forstyrrelser i benmetabolismen
ATE230741T1 (de) 3-tetrahydropyridin-4-yl-indole zur behandlung von psychotischen störungen
NO20010390D0 (no) Behandling av angstsykdommer
PT1051172E (pt) Metodo para tratamento da dpco
NO20012612D0 (no) Isonipecotamider for behandling av integren-formidlede lidelser
PT1200447E (pt) Oxazinocarbazoles para o tratamento de doencas do snc
AR026062A1 (es) Tratamiento de desordenes oculares
ID30458A (id) Osanetan dalam pengobatan gangguan jiwa
ID24922A (id) Terapi kombinasi untuk pengobatan aids
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
NO20006383D0 (no) Fremgangsmåte for behandling
DK82798A (da) Treatment of GABA-uptake related disorders
NO20012301D0 (no) Ny fremgangsmåte for behandling
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
ID29414A (id) Pengobatan depresi